Citigroup
SBIO icon

Citigroup’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Citigroup’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$52 – 6177
2026
Q1 		$52 Hold
1
– – ﹤0.01% 5642
2025
Q4 		$51 Sell
1
-44
-98% -$2.04K ﹤0.01% 5703
2025
Q3 		$1.75K Buy
+45
New +$1.55K ﹤0.01% 5514
2020
Q1 		– Sell
-70
Closed -$3K – 7756
2019
Q4 		$3K Buy
+70
New +$2.6K ﹤0.01% 7500
2019
Q3 		– Sell
-500
Closed -$18K – 7802
2019
Q2 		$18K Hold
500
– – ﹤0.01% 7129
2019
Q1 		$18K Sell
500
-300
-38% -$10K ﹤0.01% 7015
2018
Q4 		$23K Sell
800
-700
-47% -$23.2K ﹤0.01% 6813
2018
Q3 		$59K Hold
1,500
– – ﹤0.01% 6381
2018
Q2 		$56K Hold
1,500
– – ﹤0.01% 6205
2018
Q1 		$51K Sell
1,500
-405
-21% -$14.2K ﹤0.01% 6158
2017
Q4 		$62K Hold
1,905
– – ﹤0.01% 6026
2017
Q3 		$59K Hold
1,905
– – ﹤0.01% 5910
2017
Q2 		$53K Hold
1,905
– – ﹤0.01% 5746
2017
Q1 		$49K Buy
1,905
+815
+75% +$20.3K ﹤0.01% 5715
2016
Q4 		$25K Buy
1,090
+200
+22% +$4.79K ﹤0.01% 6447
2016
Q3 		$23K Buy
+890
New +$22.2K ﹤0.01% 6134
2016
Q1 		– Sell
-100
Closed -$3K – 7725
2015
Q4 		$3K Buy
+100
New +$3.06K ﹤0.01% 7198

Other funds holding SBIO

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PWA
Phoenix Wealth Advisors Chapel Hill, North Carolina $297M AUM 17.87% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

Citigroup's SBIO Position: Q2 2026 in Review

Citigroup sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 1 share — an estimated $52 sold.

Citigroup first reported a position in SBIO in Q4 2015 and held it in 17 quarters. The position peaked at $62K in Q4 2017. 25 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Citigroup reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 1 ALPS Medical Breakthroughs ETF share in Q2 2026, an estimated $52.
  • Citigroup first reported a position in ALPS Medical Breakthroughs ETF in Q4 2015 and held it in 17 quarters.
  • Citigroup's ALPS Medical Breakthroughs ETF position peaked at $62K in Q4 2017.
  • 25 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.